Darunavir 800 MG Oral Tablet — RxCUI 1359269
RxNorm drug concept · Semantic clinical drug
RxCUI 1359269
Semantic clinical drug · SCD
● Current RxNorm concept 30 FDA products
40 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1359269
Official nameDarunavir 800 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdarunavir (as darunavir ethanolate) 800 MG Oral Tablet
FDA products mapped30
Package NDCs mapped40
Reported Medicaid activity (SDUD)10,446 prescriptions · 31 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Darunavir: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No — darunavir really does need ritonavir to work properly. On its own, your body breaks darunavir down too quickly for it to control HIV. Ritonavir slows that breakdown, which kee...
- Why do I have to take ritonavir with my darunavir — can't I just take darunavir alone?
- Yes, it really does. Taking darunavir tablets with food increases how much the drug gets into your bloodstream by about 40% compared to taking it on an empty stomach. So the instru...
- Does it matter whether I take darunavir with food?
🕸️ Concept Web — How Darunavir 800 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Darunavir 800 MG Oral Tablet
RxCUI 1359269 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Darunavir
460132IN
-
Darunavir
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Prezista
643075BN
-
Prezista
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Darunavir Oral Tablet
643073SCDF -
Darunavir Oral Product
1157184SCDG -
Darunavir Pill
1157185SCDG -
Darunavir Oral Tablet [Prezista]
643077SBDF -
Prezista Oral Product
1177658SBDG -
Prezista Pill
1177659SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Darunavir Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Darunavir 800 MG
1359268SCDC -
Darunavir 800 MG Oral Tablet [Prezista]
1359271SBD -
Darunavir 800 MG [Prezista]
1359270SBDC
-
Darunavir 800 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Darunavir 800 MG
SCDC · 1359268 -
Darunavir Oral Tablet
SCDF · 643073 -
Darunavir Oral Product
SCDG · 1157184 -
Darunavir Pill
SCDG · 1157185
Brand-Name Concepts
-
Darunavir 800 MG Oral Tablet [Prezista]
SBD · 1359271 -
Darunavir 800 MG [Prezista]
SBDC · 1359270 -
Darunavir Oral Tablet [Prezista]
SBDF · 643077 -
Prezista Oral Product
SBDG · 1177658 -
Prezista Pill
SBDG · 1177659 -
Prezista
BN · 643075
📦 FDA Products & Package NDCs
30 products · 40 package NDCs
40 package NDCs map to RxCUI 1359269 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 31722-0088-60 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-088-60) | Darunavir | Camber Pharmaceuticals, Inc. | 2025-01-21 |
| 31722-0089-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-089-30) | Darunavir | Camber Pharmaceuticals, Inc. | 2025-01-21 |
| 43598-0704-05 | 500 TABLET, FILM COATED in 1 BOTTLE (43598-704-05) | Darunavir | Dr.Reddys Laboratories Inc | 2023-11-29 |
| 43598-0704-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-704-60) | Darunavir | Dr.Reddys Laboratories Inc | 2023-11-29 |
| 43598-0705-05 | 500 TABLET, FILM COATED in 1 BOTTLE (43598-705-05) | Darunavir | Dr.Reddys Laboratories Inc | 2023-11-29 |
| 43598-0705-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-705-30) | Darunavir | Dr.Reddys Laboratories Inc | 2023-11-29 |
| 59651-0085-60 | 60 TABLET, FILM COATED in 1 BOTTLE (59651-085-60) | Darunavir | Aurobindo Pharma Limited | 2023-11-28 |
| 59651-0086-30 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-086-30) | Darunavir | Aurobindo Pharma Limited | 2023-11-28 |
| 59676-0562-01 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-562-01) | PREZISTA | Janssen Products LP | 2008-03-08 |
| 59676-0563-01 | 480 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-563-01) | PREZISTA | Janssen Products LP | 2009-01-14 |
| 59676-0564-01 | 240 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-564-01) | PREZISTA | Janssen Products LP | 2009-04-27 |
| 59676-0565-01 | 1 BOTTLE, GLASS in 1 CARTON (59676-565-01) / 200 mL in 1 BO... | PREZISTA | Janssen Products LP | 2011-12-16 |
| 59676-0566-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (59676-566-30) | PREZISTA | Janssen Products LP | 2012-11-09 |
| 60219-1144-06 | 1 BOTTLE, PLASTIC in 1 CARTON (60219-1144-6) / 60 TABLET, F... | Darunavir | Amneal Pharmaceuticals NY LLC | 2023-12-09 |
| 60219-1145-03 | 1 BOTTLE, PLASTIC in 1 CARTON (60219-1145-3) / 30 TABLET, F... | Darunavir | Amneal Pharmaceuticals NY LLC | 2023-12-09 |
| 60687-0808-21 | 30 BLISTER PACK in 1 CARTON (60687-808-21) / 1 TABLET in 1... | Darunavir | American Health Packaging | 2024-06-09 |
| 60687-0819-21 | 30 BLISTER PACK in 1 CARTON (60687-819-21) / 1 TABLET in 1... | Darunavir | American Health Packaging | 2024-06-09 |
| 63629-5686-01 | 15 TABLET in 1 BOTTLE (63629-5686-1) | Darunavir 600 and 800 mg | Bryant Ranch Prepack | 2025-06-05 |
| 68071-3910-03 | 3 TABLET, FILM COATED in 1 BOTTLE (68071-3910-3) | Darunavir | NuCare Pharmaceuticals, Inc. | 2025-11-04 |
| 68180-0345-07 | 60 TABLET, FILM COATED in 1 BOTTLE (68180-345-07) | DARUNAVIR | Lupin Pharmaceuticals, Inc. | 2023-06-01 |
| 68180-0346-06 | 30 TABLET, FILM COATED in 1 BOTTLE (68180-346-06) | DARUNAVIR | Lupin Pharmaceuticals, Inc. | 2023-06-01 |
| 69097-0244-02 | 30 TABLET in 1 BOTTLE (69097-244-02) | Darunavir 600 and 800 mg | Cipla USA Inc. | 2023-11-29 |
| 69097-0248-03 | 60 TABLET in 1 BOTTLE (69097-248-03) | Darunavir 600 and 800 mg | Cipla USA Inc. | 2023-11-29 |
| 70771-1745-05 | 500 TABLET, FILM COATED in 1 BOTTLE (70771-1745-5) | Darunavir | Zydus Lifesciences Limited | 2024-05-01 |
| 70771-1745-06 | 60 TABLET, FILM COATED in 1 BOTTLE (70771-1745-6) | Darunavir | Zydus Lifesciences Limited | 2024-05-01 |
| 70771-1745-08 | 180 TABLET, FILM COATED in 1 BOTTLE (70771-1745-8) | Darunavir | Zydus Lifesciences Limited | 2024-05-01 |
| 70771-1746-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1746-3) | Darunavir | Zydus Lifesciences Limited | 2024-05-01 |
| 70771-1746-05 | 500 TABLET, FILM COATED in 1 BOTTLE (70771-1746-5) | Darunavir | Zydus Lifesciences Limited | 2024-05-01 |
| 70771-1746-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1746-9) | Darunavir | Zydus Lifesciences Limited | 2024-05-01 |
| 71335-2611-01 | 15 TABLET, FILM COATED in 1 BOTTLE (71335-2611-1) | Darunavir | Bryant Ranch Prepack | 2026-03-11 |
| 72205-0184-60 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-184-60) | Darunavir | Novadoz Pharmaceuticals LLC | 2023-11-29 |
| 72205-0185-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-185-30) | Darunavir | Novadoz Pharmaceuticals LLC | 2023-11-29 |
| 72578-0147-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72578-147-05) | Darunavir | Viona Pharmaceuticals Inc | 2024-05-01 |
| 72578-0147-14 | 60 TABLET, FILM COATED in 1 BOTTLE (72578-147-14) | Darunavir | Viona Pharmaceuticals Inc | 2024-05-01 |
| 72578-0147-28 | 180 TABLET, FILM COATED in 1 BOTTLE (72578-147-28) | Darunavir | Viona Pharmaceuticals Inc | 2024-05-01 |
| 72578-0148-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72578-148-05) | Darunavir | Viona Pharmaceuticals Inc | 2024-05-01 |
| 72578-0148-06 | 30 TABLET, FILM COATED in 1 BOTTLE (72578-148-06) | Darunavir | Viona Pharmaceuticals Inc | 2024-05-01 |
| 72578-0148-16 | 90 TABLET, FILM COATED in 1 BOTTLE (72578-148-16) | Darunavir | Viona Pharmaceuticals Inc | 2024-05-01 |
| 76282-0737-60 | 60 TABLET in 1 BOTTLE (76282-737-60) | darunavir | EXELAN PHARMACEUTICALS INC. | 2024-01-19 |
| 76282-0738-30 | 30 TABLET in 1 BOTTLE (76282-738-30) | darunavir | EXELAN PHARMACEUTICALS INC. | 2024-01-19 |
Observed labelers:
Viona Pharmaceuticals Inc (6) ·
Zydus Lifesciences Limited (6) ·
Janssen Products LP (5) ·
Dr.Reddys Laboratories Inc (4) ·
American Health Packaging (2) ·
Amneal Pharmaceuticals NY LLC (2)
· +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.